Pyrukynd 50 MG 4-Week Pack

RxCUI: 2594795
RxNorm name: Pyrukynd 50 MG 4-Week Pack
Display name: Pyrukynd 50 MG 4-Week Pack
Full name: Pyrukynd 50 MG 4-Week Pack
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PYRUKYND	MITAPIVAT	Agios Pharmaceuticals, Inc.	4ccee896-e313-4c6c-9674-b4746ada0a90	2026-06-30	Warnings, Adverse reactions	Exact identifier rxcui: 2594795

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
4ccee896-e313-4c6c-9674-b4746ada0a90	{56 (mitapivat 50 MG Oral Tablet [Pyrukynd]) } Pack [Pyrukynd 50 MG 4-Week] [BPCK] · Pyrukynd 50 MG 4-Week Pack [PSN] · Pyrukynd 50 MG 4-Week Pack [SY]	3	9	These highlights do not include all the information needed to use PYRUKYND safely and effectively. See full prescribing information for PYRUKYND. PYRUKYND ® (mitapivat) tablets, for oral use Initial U.S. Approval: 2022	20260422